Spondylitis and Arthritis Due to Mycoplasma hominis: The Case for Awareness in Undefined Pleuropneumonia
Sir-Mycoplasma hominis rarely causes pneumonia [1] . Because special culture media are required to detect M. hominis and are not often requested, the lack of clinical suspicion and/or detection may result in inappropriate treatment. As a consequence, the risk of bacterial seeding is increased, as is shown in the case we report.
A 48-year-old woman with a history of primary hypogammaglobulinemia was hospitalized because of osteoporotic fracture of the T12 vertebra. Her medical history included recurrent pneumonia, polyarthritis, and chondrocalcinosis of the right knee. Five weeks after admission to the hospital, she developed bilateral pneumonia (figure 1), which deteriorated to ventilator-dependent respiratory failure, despite treatment with amoxicillin-clavulanate followed by treatment with ceftriaxone plus clarithromycin. M. hominis is a commensal of humans and mainly causes genitourinary tract infection [2] . The patient described here had neither a recent infection nor recent manipulation of the genitourinary tract. Extragenitourinary infections caused by M. hominis, such as arthritis, spondylitis, brain abscess, meningitis, and respiratory tract infections have rarely been reported [3] . Most of these cases, much like the case we report, occurred in an immunocompromised host [1, 4] . In the case that we report, it is likely that the primary infection was pleuropneumonia due to M. hominis, because of the sequence of manifestations of infection and because of the favorable course of pneumonia only after administration of doxycycline. It is interesting that M. hominis was seeding to 2 foci that had previous pathologic findings-namely, the fractured vertebra and the knee that had active crystal synovitisillustrating that these sites of inflammation represented a locus minoris resistentiae.
Antibiotic therapy for M. hominis is not standardized and depends on the type of infection. Tetracyclines are given mainly for bone and joint infections. However, resistant strains of M. hominis have been reported [5] . Clindamycin, erythromycin, and ciprofloxacin are documented alternatives but are not used as first-line therapy [1, 4] . In the case of culture-negative pleuropneumonia, clinical awareness of M. hominis is important, so that specific culture media can be requested and organ failure and bacterial seeding can be prevented.
